Evoke Pharma Inc (EVOK) [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	2.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0
Revenue growth	55.0%	6929.0%
Cost of goods sold	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
Gross profit	2.5	1.6	-0.1	0.0	0.0	0.0	0.0	0.0
Gross margin	100.0%	100.0%	-276.7%
Selling, general and administrative [+]	10.3	9.8	6.4	3.7	3.9	4.1	3.6	3.7
General and administrative					3.9	4.1	3.6	3.7
Research and development	0.3	0.6	6.6	3.4	4.1	7.1	7.0	8.2
Other operating expenses	0.6	0.2
EBIT [+]	-8.7	-8.9	-13.0	-7.2	-8.0	-11.2	-10.5	-11.8
EBIT growth	-2.9%	-31.6%	82.4%	-10.7%	-28.6%	6.5%	-10.8%	-10.1%
EBIT margin	-345.3%	-551.5%	-56678.3%
Interest expense, net [+]			0.1	0.0	0.0	0.0	0.3	0.3
Interest expense	0.5	0.5	0.1				0.3	0.3
Interest income				0.0	0.0	0.0
Other income (expense), net [+]	0.9	0.9	0.0		0.4	-1.0	0.1
Change in fair value of warrants					0.4	-1.0	0.6
Other								-0.3
Pre-tax income	-8.2	-8.5	-13.2	-7.1	-7.6	-12.2	-10.7	-12.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-8.2	-8.5	-13.2	-7.1	-7.6	-12.2	-10.7	-12.1
Net margin	-327.8%	-527.7%	-57144.5%

Basic EPS [+]	($2.62)	($3.18)	($0.52)	($0.32)	($0.46)	($0.82)	($1.15)	($1.87)
Growth	-17.8%	516.9%	61.5%	-29.9%	-44.5%	-28.7%	-38.4%	-14.9%
Diluted EPS [+]	($2.62)	($3.18)	($0.52)	($0.32)	($0.46)	($0.82)	($1.15)	($1.87)
Growth	-17.8%	516.9%	61.5%	-29.9%	-44.3%	-28.9%	-38.4%	-14.9%

Shares outstanding (basic) [+]	3.1	2.7	25.5	22.3	16.6	14.9	9.3	6.5
Growth	17.2%	-89.5%	14.3%	34.3%	11.4%	59.5%	44.0%	7.5%
Shares outstanding (diluted) [+]	3.1	2.7	25.5	22.3	16.6	15.0	9.3	6.5
Growth	17.2%	-89.5%	14.3%	34.3%	11.0%	60.1%	44.0%	7.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.